M&A Deal Summary

Maravai Acquires MyChem

On January 28, 2022, Maravai acquired life science company MyChem for 240M USD

Acquisition Highlights
  • This is Maravai’s 3rd transaction in the Life Science sector.
  • This is Maravai’s largest (disclosed) transaction.
  • This is Maravai’s 4th transaction in the United States.
  • This is Maravai’s 2nd transaction in California.

M&A Deal Summary
Date 2022-01-28
Target MyChem
Sector Life Science
Buyer(s) Maravai
Deal Type Add-on Acquisition
Deal Value 240M USD
Advisor(s) BroadOak Capital Partners (Financial)
Morrison & Foerster (Legal)

Target

MyChem

San Diego, California, United States
MyChem is a privately held provider of proprietary, ultra-pure nucleotides to customers in the diagnostics, pharma, genomics, and research markets. MyChem products include modified nucleotides and other inputs used for mRNA synthesis. MyChem is based in San Diego, California.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Maravai

San Diego, California, United States
Category Company
Founded 2020
Sector Life Science
Employees570
Revenue 289M USD (2023)
DESCRIPTION

Maravai’s mission is to build a transformative company in the in vitro diagnostics and life sciences tools markets by acquiring outstanding businesses in these spaces and accelerating their growth. Maravai was founded in 2020 and is based in San Diego, California.

DEAL STATS #
Overall 4 of 5
Sector (Life Science) 3 of 4
Type (Add-on Acquisition) 4 of 4
State (California) 2 of 2
Country (United States) 4 of 4
Year (2022) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-07 Vector Laboratories

Newark, California, United States

Vector Laboratories is a provider of life science products, including labeling and detection reagents, that help medical and scientific researchers visualize cells in experiments that are central to the understanding of cancer and other diseases. Vector Laboratories was founded in 1976 and is based in Newark, California.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-11-07 Officinae Bio - DNA and RNA business

Venice, Italy

Officinae Bio's DNA and RNA business generates libraries of precisely engineered UTRs (untranslated regions), optimizing efficacy and safety through enhanced translation and tissue-specificity. Officinae Bio's DNA and RNA business is based in Venice, Italy.

Buy -
Mergr

Product

Company

Legal